Clinical Medicine Equipment With Liquid Biopsy Solutions For Breast Cancer Applications
-
Manufactured by Bioceptbased in USA
As healthy and diseased tissue interact with the bloodstream, they release both cellular and genetic material into the circulation. These materials are referred to as “cell-free” DNA (cfDNA), and circulating tumor cells (CTCs). Conventional blood collection tubes contain only anti-coagulants, designed to prevent blood clotting. Over time, and without stabilization, nucleated blood ...
-
Manufactured by Bioceptbased in USA
This kit detects EGFR mutations in DNA derived from blood plasma or FFPE tissue sections to give insight into cancer characteristics and provide Biomarker status of tumors such as non-small cell lung ...
-
Manufactured by Bioceptbased in USA
his kit detects BRAF V600 mutations in DNA derived from blood plasma or FFPE tissue sections to give insight into cancer characteristics and provide Biomarker status of tumors such as ...
-
Manufactured by Bioceptbased in USA
Combining Biocept’s Liquid Biopsy biomarker testing expertise with Oncomine™ from Thermo Fisher Scientific’s next-generation sequencing and decision support ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you